All stock lists
Bioceres Crop Solutions Corp. (NASDAQ:BIOX)
AR · Delayed Price · Currency is USD
0.22-0.01 (-4.18%)
Insider Score
––Not scored
BIOX Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
BIOX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 57.00 M | 38.20 M | 73.67 M | 77.44 M | 74.37 M | 59.60 M |
| Revenue Growth (YoY) | -23.35 % | -35.90 % | -25.49 % | -16.39 % | -40.18 % | -29.05 % |
| Cost of Revenue | 43.20 M | 26.70 M | 47.36 M | 41.79 M | 51.02 M | 36.12 M |
| Gross Profit | 13.80 M | 11.50 M | 26.31 M | 35.64 M | 23.35 M | 23.47 M |
| SG&A Expense | 23.90 M | 0.00 | 12.63 M | 16.54 M | 22.66 M | 21.01 M |
| R&D Expense | 0.00 | 0.00 | 2.35 M | 5.72 M | 2.65 M | 3.66 M |
| Operating Expenses | 23.90 M | 18.00 M | 18.49 M | 27.88 M | 30.26 M | 22.54 M |
| Operating Income | -10.10 M | -6.50 M | 7.82 M | 7.76 M | -6.92 M | 933.21 K |
| Pretax Income | -30.00 M | -17.50 M | -1.37 M | -5.37 M | -44.92 M | -5.60 M |
| Tax Provision | 1.80 M | -4.00 M | 3.11 M | 2.08 M | 6.75 M | -4.01 M |
| Net Income | -27.50 M | -12.30 M | -183.04 M | -7.33 M | -47.89 M | -1.30 M |
| EPS (Basic) | -0.39 | -0.19 | -2.88 | -0.12 | -0.70 | -0.02 |
| EPS (Diluted) | -0.39 | -0.19 | -2.88 | -0.12 | -0.70 | -0.02 |
| Shares Outstanding | 63.60 M | 63.60 M | 63.48 M | 63.43 M | 63.20 M | 62.80 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.